Greg Divis

(Gregory Divis Jr.)

Currently holds positions in Avadel Pharmaceuticals PLC, Jaguar Health Inc and Amag Pharma Usa Inc

Positions

Position Company Period
Chief Executive Officer, Chief Operating Officer, Executive Vice President, Director Avadel Pharmaceuticals PLC June 3, 2019 -
Director Jaguar Health Inc June 14, 2018 -
President, Chief Executive Officer, Director Amag Pharma Usa Inc Sept. 16, 2013 -
Interim Chief Executive Officer, Chief Operating Officer, Executive Vice President Avadel Pharmaceuticals PLC Jan. 1, 2019 - June 3, 2019
Chief Operating Officer, Chief Commercial Officer, Executive Vice President Avadel Pharmaceuticals PLC March 22, 2018 - Jan. 1, 2019
Executive Vice President, Chief Commercial Officer Avadel Pharmaceuticals PLC Jan. 1, 2017 - March 22, 2018
President, Chief Executive Officer Amag Pharma Usa Inc Nov. 17, 2010 - Sept. 16, 2013
Greg Divis's trades of Avadel Pharmaceuticals PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-10 2024-12-09 B Purchase
402 +4.2%
9.82
USD 3,948
402 +4.2% 9.82 USD 3,948
2024-12-10 2024-12-06 B Purchase
9,598 +inf%
9.98
USD 95,759
9,598 +inf% 9.98 USD 95,759
2023-08-10 2023-08-10 B Purchase
10,000 +6.7%
13.20
USD 131,997
10,000 +6.7% 13.20 USD 131,997
2022-05-31 2022-05-27 B Purchase
50,000 +50.5%
2.05
USD 102,500
50,000 +50.5% 2.05 USD 102,500
2020-08-13 2020-08-12 B Purchase
13,000 +15.1%
7.78
USD 101,156
13,000 +15.1% 7.78 USD 101,156
2019-11-19 2019-11-15 B Purchase
19,000 +28.3%
5.13
USD 97,470
19,000 +28.3% 5.13 USD 97,470
2018-06-27 2018-06-26 B Purchase
16,000 +48.3%
6.00
USD 96,000
16,000 +48.3% 6.00 USD 96,000
2017-09-14 2017-09-12 B Purchase
10,600 +inf%
9.32
USD 98,760
10,600 +inf% 9.32 USD 98,760
// ... existing code ... // ... rest of the file ...